$NVDA NEWS Nvidia stock tumbles as new Biden rule threatens new curbs on chip exports KOSDAQ - Delayed Quote • KRW DNF Co.,Ltd. (092070.KQ) Follow Compare 9,790.00 -330.00 (-3.26%) At close: 3:30:30 PM GMT+9 Related News Southern California Edison parent's stock falls amid investigation, lawsuit over alleged role in LA wildfires Edison International — the parent company of the utility Southern California Edison — has seen its stock remain under pressure as lawsuits begin over its potential role in the fires that have ravaged parts of Southern California. Moderna plunges, retail guidance, bitcoin falls: Market Minute The Dow Jones Industrial Average (^DJI) is on the rise, while the S&P 500 (^GSPC) and Nasdaq Composite (^IXIC) are falling mid-morning Monday. Moderna (MRNA) shares are plunging after the company cut its 2025 sales guidance. A number of retailers updated their quarterly guidance, including Lululemon (LULU), Macy's (M), and Abercrombie & Fitch (ANF). Bitcoin (BTC-USD) is trading around $92,000. the cryptocurrency has fallen about 10% over the course of the last month. Yahoo Finance Senior Reporter Alexandra Canal recaps some of the day's top stories in the latest Market Minute, For more expert insight and the latest market action, click here. This post was written by Stephanie Mikulich. Moderna stock plunges on sales forecast cut Moderna (MRNA) shares tumble after the pharmaceutical company lowered its sales forecast amid weak demand for COVID and RSV vaccines. Seana Smith and Brad Smith outline what investors need to know about the sales cut. The sales outlook cut comes ahead of President-elect Donald Trump’s return to the White House, fueling uncertainty given that Trump’s Food and Drug Administration (FDA) nomination, Robert F. Kennedy Jr., has been outspoken with his antivaccine views. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Naomi Buchanan. Stock Market Today: Dow Jones Up, Donald Trump Stock Rockets; Mark Zuckerberg Says This, Rocks Quantum Stocks (Live Coverage) The Dow Jones rose and other indexes were mixed on the stock market today. A Donald Trump stock soared. Bill Ackman made an offer. Johnson & Johnson to Acquire Intra-Cellular in $15 Billion Deal Pharmaceutical giants have recently shown new enthusiasm for mental-health treatments with vast but unrealized promise. Biogen proposes acquisition of partner Sage Therapeutics The proposed deal comes soon after Sage implemented a restructuring plan to focus on Zurzuvae’s launch in postpartum depression. Honeywell Plans Breakup Under Pressure From Elliott (Bloomberg) -- Honeywell International Inc. is poised to proceed with a breakup following pressure from activist Elliott Investment Management to split, people familiar with the matter said.Most Read from BloombergThese Homes Withstood the LA Fires. Architects Explain WhyA Blueprint for Better Bike LanesWhat Robotaxis Brought San FranciscoAmbitious High-Speed Rail Plans Advance in the Baltic RegionThe Charlotte, North Carolina-based industrial conglomerate is planning to split into two independe Why U.S. Steel Stock Soared Today U.S. Steel (NYSE: X) has been in the news for months since Japan's Nippon Steel made a generous offer for the iconic American steelmaker. Nippon's $14.9 billion bid in late 2023 represented a nearly 40% premium to U.S. Steel's share price at the time. Most recently, President Biden blocked Nippon's $55-per-share cash bid on national security concerns. BridgeBio, ARS Pharma, Harmony Bio Shine At JPM. But SpringWorks, Beam Take Their Lumps. Biotech stocks put up a split showing at JPM, where names like BridgeBio, ARS and Harmony stood out with strong preliminary reports. These Stocks Are Moving the Most Today: Micron, Intra-Cellular Therapies, and More Nvidia pushes back on new artificial-intelligence regulations, Moderna issues weak revenue guidance, and Intra-Cellular Therapies is being acquired by Johnson & Johnson for nearly $15 billion. Moderna’s Struggles Could Complicate Bird Flu Fight. What It Means for a Potential Vaccine. Moderna continues to cut costs, which could raise questions about the vaccine playbook used during the Covid-19 pandemic. U.S. Steel Stock Is Rising on Hopes for Other Bidders The bidding war for United States Steel could get more complicated—and dramatic. Nucor declined to comment to Barron’s. Cleveland-Cliffs and U.S. Steel didn’t immediately respond to a request for comment. U.S. Steel stock was up 6.7% at $36.57 in late trading Monday. Cleveland-Cliffs and Nucor Mull Fresh Bid for U.S. Steel Cleveland-Cliffs is discussing joining with Nucor on a possible bid for U.S. Steel that is still likely months away from happening, according to people familiar with the matter. U.S. Steel had planned to sell itself to Japanese steelmaker Nippon Steel but President Biden earlier this month blocked the transaction over concerns about foreign ownership and national security. Cleveland-Cliffs aims to purchase all of U.S. Steel with cash, and then sell Big River Steel, a mill in northeast Arkansas, to Nucor, the people said. Cleveland-Cliffs and Nucor Consider Joint US Steel Bid (Bloomberg) -- Cleveland-Cliffs Inc. is partnering with Nucor Corp. to weigh a potential joint bid for United States Steel Corp., according to a person familiar with the matter. Most Read from BloombergThese Homes Withstood the LA Fires. Architects Explain WhyA Blueprint for Better Bike LanesWhat Robotaxis Brought San FranciscoAmbitious High-Speed Rail Plans Advance in the Baltic RegionThe companies are considering an offer that would involve Cleveland-Cliffs acquiring most of US Steel and Nucor The Nasdaq and the S&P 500 slump as Biden's new AI rules rattle Nvidia and other tech stocks The Nasdaq and S&P 500 fell on Monday as a continued selloff in tech stocks extended losses sparked by stronger-than-expected job reports. Moderna Crashes 21%. 'No Inflection In Sight' After Guidance Cut, CMV Shortfall. Moderna stock crashed Monday after the firm slashed its outlooks for 2024 and 2025, and announced an expanded cost-cutting initiative. Why Macy's (M) Stock Is Down Today Shares of department store chain Macy’s (NYSE:M) fell 7.3% in the afternoon session after the company disclosed disappointing preliminary fourth-quarter results, projecting sales to fall just below the lower end of its earlier forecast of $7.8 billion to $8.0 billion. Notably, same-store sales are expected to remain flat compared to the previous year. In addition, earnings are expected to remain within the previous range of $1.40 to $1.65. Overall, the results were underwhelming, given the some Abercrombie and Fitch (ANF) Stock Trades Down, Here Is Why Shares of young adult apparel retailer Abercrombie & Fitch (NYSE:ANF) fell 19.9% in the morning session after the company reported underwhelming sales and earnings forecasts, falling short of high expectations for retail stocks fueled by strong demand ahead of the holiday shopping season. ANF bumped its sales growth outlook for Q4 2024 to a range of 7-8% from a prior range of 5-7%. However, this modest increase lags far behind the robust double-digit growth the company achieved in the same quart Why EIX Stock Is Plunging Today Edison International (EIX) stock is sinking 11% today following reports that wind speeds in the Los Angeles area are expected to accelerate in the coming days. A number of the customers of EIX’s Southern California Edison subsidiary have been affected by the California wildfires. Southern California Edison is an electric utility. Accelerating Winds Expected in […] Cancer-Focused Phio Pharmaceuticals Stock Gains 300% On Monday - Here's Why On Monday, Phio Pharmaceuticals Corp. (NASDAQ:PHIO) stock skyrocketed with a strong session volume of 201.04 million, compared to the average volume of 362.72k, according to data from Benzinga Pro. Phio reported pathologic responses for patients enrolled in the 2nd cohort, which includes two patients with a complete response or 100% tumor clearance. Phio’s ongoing Phase 1b clinical study is designed to evaluate the safety and tolerability of neoadjuvant use of intratumoral PH-762 in Stages 1, 2 Performance Overview Trailing total returns as of 1/13/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index Return 092070.KQ KOSPI Composite Index YTD +11.00% +3.75% 1-Year -54.01% -1.41% 3-Year -51.38% -15.95%